Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes

The prevalence rate of thalassemia, which is endemic in Southeast Asia, the Middle East, and the Mediterranean, exceeds 100,000 live births per year. There are many genetic variants in thalassemia with different pathological severity, ranging from a mild and asymptomatic anemia to life-threatening c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kontoghiorghe, Christina N, Kontoghiorghes, George J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745840/
https://www.ncbi.nlm.nih.gov/pubmed/26893541
http://dx.doi.org/10.2147/DDDT.S79458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745840/
https://www.ncbi.nlm.nih.gov/pubmed/26893541
http://dx.doi.org/10.2147/DDDT.S79458

Ejemplares similares